title: Deal watch: Merck invests in pioneering cytomegalovirus programme.
authors.forename: Sarah
authors.initials: S
authors.lastname: Crunkhorn
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D007449:Investments
chemical_list: D000998:Antiviral Agents